by American Heart Association Credit: Unsplash/CC0 Public Domain Sarpogrelate, an antiplatelet medication, has potential as a new heart failure therapy and, according to researchers, could potentially decrease health care costs associated with cardiovascular disease, according to preliminary animal research presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2021. Cardiac hypertrophy is the abnormal enlargement, or thickening, of...
